Veradermics, Inc
MANE · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Hollander David: Form 4
Insider disclosure · Filed · Report period 01 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form SCHEDULE 13D/A
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- MANE · 922967104 - Common stock, par value $0.00001 per share
Company details and SEC sources
CIK 0001827635 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- MANE on NYSE
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 470 James Street, New Haven, CT, 06513
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields